Bio-Tech-Business SPRL

Bio-Tech-Business reported total assets of 52,374 € at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Sep 2026).

Company number (CBE) 0637.774.802 · VAT BE0637774802
1050 Ixelles
active in Business and other management consultancy activities (NACE 70200)
operating since 15 Sep 2015 (≈ 11 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Bio-Tech-Business shows with a free account.

See the score
Profile
SPRL since 2015
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−15,494 €
Equity30,262 €
Cash1,377 €
EBITDA−28,304 €
Total assets52,374 €
Solvency57.8%
The line marks its sector median: 50.7% (6274 companies).

Change 2022 → 2025: Equity -42 % Total assets -24 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Bio-Tech-Business's annual accounts

20252024202320222021
Net result−15,494 €
Equity30,262 €
Cash1,377 €
EBITDA−28,304 €
Total assets52,374 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 21 Sep 2026
  • Year ended 31 Dec 2024filed on 06 Oct 2025
  • Year ended 31 Dec 2023filed on 09 Dec 2024
  • Year ended 31 Dec 2022filed on 10 Dec 2024
  • Year ended 31 Dec 2021filed on 27 Oct 2022

Bio-Tech-Business's financial analysis

Management and control of Bio-Tech-Business

1 active director(s) in the register.

Bio-Tech-Business's shareholders and holdings →

Bio-Tech-Business's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0637.774.802
VAT number
BE0637774802
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SPRL
Incorporated
15 Sep 2015
Registered office
1050 Ixelles
Latest accounts
2025 · filed on 21 Sep 2026
Activity
Business and other management consultancy activities (NACE 70200)

Bio-Tech-Business (SPRL) has been based in Ixelles since 2015, active in: business and other management consultancy activities. For 2025, it reports a net loss of 15,494 € and equity of 30,262 €; its revenue is not published. Its solvency stands at 57.8%, above the median of its sector (50.7%).

Companies similar to Bio-Tech-Business

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Bio-Tech-Business

What is the revenue of Bio-Tech-Business?

Bio-Tech-Business files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Bio-Tech-Business?

In Belgium, the VAT number is the company number prefixed with BE: BE0637774802 for Bio-Tech-Business, if the company is VAT-registered. Its company number (CBE) is 0637.774.802.

Where is the registered office of Bio-Tech-Business?

According to the CBE register, the registered office of Bio-Tech-Business is in 1050 Ixelles.

What is the equity of Bio-Tech-Business?

At the close of the 2025 financial year, the equity of Bio-Tech-Business amounts to 30,262 €, a solvency of 57.8% of total assets.

Who manages Bio-Tech-Business?

The register lists 1 active mandates at Bio-Tech-Business. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Bio-Tech-Business

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 26 Sep 2026

No credit card, no commitment.

What each plan unlocks →